Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel DiseaseMarieke J. H. Coenen, H. Akol, Dirk J. de Jong et al.|Gastroenterology|2015Cited by 199
Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY StudyMerve Sivridaş, Luc J. J. Derijks, Theo Rispens et al.|Pharmaceutics|2023Cited by 17
Implications of Tioguanine Dosing in IBD Patients with a TPMT DeficiencyDebbie S. Deben, Dennis R. Wong, Luc J. J. Derijks et al.|Metabolites|2023Cited by 1
Implications of tioguanine dosing in IBD patients with a TPMT deficiencyDebbie S. Deben, Dennis R. Wong, Luc J. J. Derijks et al.|Research Square|2023Cited by 0